A dose-escalation study of docetaxel, oxaliplatin and S-1 (DOS) as a first-line therapy for patients with unresectable metastatic gastric cancer.

被引：0
|
作者：
Sato, Yasushi
Sagawa, Tamotsu
Takahashi, Yasuo
Ohnuma, Hiroyuki
Hamaguchi, Kyoko
Hirakawa, Masahiro
Fujikawa, Koshi
Okamoto, Koichi
Miyamoto, Hiroshi
Muguruma, Naoki
Takayama, Tetsuji
机构：
[1] Tokushima Univ, Grad Sch Biomed Sci, Tokushima, Japan
[2] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan
[3] Sapporo Med Univ, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.174
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
174
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Docetaxel and S-1 as a First-line Treatment in Patients with Advanced or Recurrent Gastric Cancer
    Tsutani, Yasuhiro
    Ohara, Masahiro
    Suzuki, Takahisa
    Minami, Kazuhito
    Miyahara, Eiji
    Kameda, Akira
    Noso, Yoshihiro
    ANTICANCER RESEARCH, 2009, 29 (07) : 2775 - 2779
  • [22] Retrospective comparative analysis of S-1 and oxaliplatin or cisplatin as first-line therapy in metastatic gastric cancer in a European population
    Koumarianou, A.
    Ntavatzikos, A.
    Vallilas, C.
    Kampoli, K.
    Kokosaiou, Z.
    Karamouzis, M. V.
    ANNALS OF ONCOLOGY, 2020, 31 : S913 - S914
  • [23] Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer
    Dae Young Zang
    Dae Hyun Yang
    Min-Jeong Kim
    Kyung Mi Jang
    Se Won Hwang
    Kyo-Sang Yoo
    Taeho Han
    Ho Young Kim
    Hyo Jung Kim
    Jung Hye Kwon
    Hun Ho Song
    Sarah Park
    Joo Young Jung
    Hyeong Su Kim
    Jung Han Kim
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 877 - 883
  • [24] Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer
    Zang, Dae Young
    Yang, Dae Hyun
    Kim, Min-Jeong
    Jang, Kyung Mi
    Hwang, Se Won
    Yoo, Kyo-Sang
    Han, Taeho
    Kim, Ho Young
    Kim, Hyo Jung
    Kwon, Jung Hye
    Song, Hun Ho
    Park, Sarah
    Jung, Joo Young
    Kim, Hyeong Su
    Kim, Jung Han
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (05) : 877 - 883
  • [25] A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer
    Sung Yong Oh
    Hyuk-Chan Kwon
    Sang-Ho Jeong
    Young-Tae Joo
    Young-Joon Lee
    Su hee Cho
    Myoung Hee Kang
    Se-il Go
    Gyeong-won Lee
    Hoon gu Kim
    Jung Hun Kang
    Investigational New Drugs, 2012, 30 : 350 - 356
  • [26] Phase II study of oxaliplatin combined with S-1 (SOX) as first-line therapy for patients with advanced gastric cancer (AGC)
    Takiuchi, H.
    Koizumi, W.
    Yamada, Y.
    Boku, N.
    Komatsu, Y.
    Fuse, N.
    Muro, K.
    Tsuburaya, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer
    Oh, Sung Yong
    Kwon, Hyuk-Chan
    Jeong, Sang-Ho
    Joo, Young-Tae
    Lee, Young-Joon
    Cho, Su Hee
    Kang, Myoung Hee
    Go, Se-il
    Lee, Gyeong-won
    Kim, Hoon Gu
    Kang, Jung Hun
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 350 - 356
  • [28] Gemcitabine and S-1 as first-line chemotherapy in patients with metastatic or advanced pancreatic cancer.
    Fang, Weijia
    Zhao, Peng
    Zheng, Yi
    Jiang, Weiqin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [29] PHASE II STUDY WITH DOCETAXEL, OXALIPLATIN AND S-1 COMBINATION CHEMOTHERAPY FOR PATIENTS WITH METASTATIC GASTRIC CANCER
    Zang, D. Y.
    Kang, Y.
    Ryoo, B.
    Ryu, M.
    Lee, S. S.
    Song, H. H.
    Jung, J. Y.
    Kwon, J. H.
    Kim, H. S.
    Choi, D. R.
    ANNALS OF ONCOLOGY, 2010, 21 : 261 - 261
  • [30] Apatinib in combination with docetaxel and S1 chemotherapy in the first-line treatment of metastatic gastric cancer.
    Xia, Ling
    Gao, Yu
    Gong, Jun
    Dai, Jing
    Peng, Jin
    He, Lilin
    Chen, Weidong
    Gong, Wei
    Yang, Lei
    Wang Wen-Bo
    Jiang, Huangang
    Xu, Hui
    Wang, Qing-Yun
    Wu, Han
    Wang, You
    Wu, Lu
    Zhou, Fuxiang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345